HIGHLIGHTS
- who: Martina Tommasini et al. from the Department of Chemical and Pharmaceutical Sciences, University of Trieste, Via Giorgieri, London E NS, UK have published the Article: Fluorescent Imprinted Nanoparticles for the Effective Monitoring of Irinotecan in Human Plasma, in the Journal: (JOURNAL)
- what: The authors focused on naphtalimide derivatives 2-6, able to emit around 520 nm when excited at 450 nm .
- how: The study was conducted in accordance with the Declaration of Helsinki and the protocol was approved by the Ethics Committee of CRO-National Cancer Institute (Project identification code 2009-25 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.